• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植受者移植物丢失和死亡的风险因素:竞争风险分析。

Risk factors for graft loss and death among kidney transplant recipients: A competing risk analysis.

机构信息

Department of Transplant Nephrology, Colombiana de Trasplantes, Bogotá, Colombia.

Department of Transplant Research, Colombiana de Trasplantes, Bogotá, Colombia.

出版信息

PLoS One. 2022 Jul 14;17(7):e0269990. doi: 10.1371/journal.pone.0269990. eCollection 2022.

DOI:10.1371/journal.pone.0269990
PMID:35834500
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9282472/
Abstract

INTRODUCTION

Kidney transplantation is the best therapeutical option for CKD patients. Graft loss risk factors are usually estimated with the cox method. Competing risk analysis could be useful to determine the impact of different events affecting graft survival, the occurrence of an outcome of interest can be precluded by another. We aimed to determine the risk factors for graft loss in the presence of mortality as a competing event.

METHODS

A retrospective cohort of 1454 kidney transplant recipients who were transplanted between July 1, 2008, to May 31, 2019, in Colombiana de Trasplantes, were analyzed to determine risk factors of graft loss and mortality at 5 years post-transplantation. Kidney and patient survival probabilities were estimated by the competing risk analysis. The Fine and Gray method was used to fit a multivariable model for each outcome. Three variable selection methods were compared, and the bootstrapping technique was used for internal validation as split method for resample. The performance of the final model was assessed calculating the prediction error, brier score, c-index and calibration plot.

RESULTS

Graft loss occurred in 169 patients (11.6%) and death in 137 (9.4%). Cumulative incidence for graft loss and death was 15.8% and 13.8% respectively. In a multivariable analysis, we found that BKV nephropathy, serum creatinine and increased number of renal biopsies were significant risk factors for graft loss. On the other hand, recipient age, acute cellular rejection, CMV disease were risk factors for death, and recipients with living donor had better survival compared to deceased-donor transplant and coronary stent. The c-index were 0.6 and 0.72 for graft loss and death model respectively.

CONCLUSION

We developed two prediction models for graft loss and death 5 years post-transplantation by a unique transplant program in Colombia. Using a competing risk multivariable analysis, we were able to identify 3 significant risk factors for graft loss and 5 significant risk factors for death. This contributes to have a better understanding of risk factors for graft loss in a Latin-American population. The predictive performance of the models was mild.

摘要

简介

肾移植是治疗慢性肾脏病(CKD)患者的最佳治疗选择。移植物丢失的风险因素通常使用 Cox 方法进行评估。竞争风险分析可能有助于确定影响移植物存活的不同事件的影响,发生感兴趣的结果可以排除另一个事件的发生。我们旨在确定在存在死亡作为竞争事件的情况下移植物丢失的风险因素。

方法

对 2008 年 7 月 1 日至 2019 年 5 月 31 日在哥伦比亚移植中心接受肾移植的 1454 例患者进行回顾性队列分析,以确定 5 年后移植物丢失和死亡率的风险因素。通过竞争风险分析估计肾和患者的生存概率。使用 Fine 和 Gray 方法为每个结果拟合多变量模型。比较了三种变量选择方法,并使用分拆法进行内部验证。使用bootstrap 技术进行重新采样。通过计算预测误差、Brier 评分、c 指数和校准图来评估最终模型的性能。

结果

169 例患者(11.6%)发生移植物丢失,137 例患者(9.4%)死亡。移植物丢失和死亡的累积发生率分别为 15.8%和 13.8%。多变量分析发现,BK 病毒肾病、血清肌酐和增加的肾活检数量是移植物丢失的显著危险因素。另一方面,受者年龄、急性细胞排斥、巨细胞病毒疾病是死亡的危险因素,活体供者的受者与尸肾移植和冠状动脉支架相比具有更好的生存。移植物丢失和死亡模型的 c 指数分别为 0.6 和 0.72。

结论

我们通过哥伦比亚的一个独特的移植项目开发了两个预测模型,用于移植后 5 年的移植物丢失和死亡。使用竞争风险多变量分析,我们能够确定 3 个移植物丢失的显著危险因素和 5 个死亡的显著危险因素。这有助于更好地了解拉丁美洲人群中移植物丢失的危险因素。模型的预测性能一般。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e918/9282472/a08f23190796/pone.0269990.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e918/9282472/7de12582384a/pone.0269990.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e918/9282472/01174331c852/pone.0269990.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e918/9282472/b22a2ec97f25/pone.0269990.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e918/9282472/a08f23190796/pone.0269990.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e918/9282472/7de12582384a/pone.0269990.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e918/9282472/01174331c852/pone.0269990.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e918/9282472/b22a2ec97f25/pone.0269990.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e918/9282472/a08f23190796/pone.0269990.g004.jpg

相似文献

1
Risk factors for graft loss and death among kidney transplant recipients: A competing risk analysis.肾移植受者移植物丢失和死亡的风险因素:竞争风险分析。
PLoS One. 2022 Jul 14;17(7):e0269990. doi: 10.1371/journal.pone.0269990. eCollection 2022.
2
An external validation of the Kidney Donor Risk Index in the UK transplant population in the presence of semi-competing events.在存在半竞争事件的情况下,对英国移植人群中的肾脏供体风险指数进行外部验证。
Diagn Progn Res. 2023 Nov 21;7(1):20. doi: 10.1186/s41512-023-00159-9.
3
Cytomegalovirus Disease, Short-Term Cardiovascular Events and Graft Survival in a Cohort of Kidney Transplant Recipients With High CMV IgG Seroprevalence.巨细胞病毒病、短期心血管事件与高 CMV IgG 血清阳性率的肾移植受者队列中的移植物存活率。
Prog Transplant. 2021 Jun;31(2):126-132. doi: 10.1177/15269248211002792. Epub 2021 Mar 19.
4
Recipient Comorbidity and Survival Outcomes After Kidney Transplantation: A UK-wide Prospective Cohort Study.受者合并症与肾移植后生存结局:英国范围前瞻性队列研究。
Transplantation. 2020 Jun;104(6):1246-1255. doi: 10.1097/TP.0000000000002931.
5
Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience.发展中国家已故供体移植术后影响移植物和患者存活的危险因素:单中心经验
Transplant Proc. 2017 Mar;49(2):270-277. doi: 10.1016/j.transproceed.2016.12.009.
6
Risk factors for death in kidney transplant patients: analysis from a large protocol biopsy registry.肾移植患者死亡的风险因素:来自大型方案活检登记处的分析。
Nephrol Dial Transplant. 2019 Jul 1;34(7):1171-1181. doi: 10.1093/ndt/gfy131.
7
Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation.移植前 HLA 抗体与当代肾移植中的延迟移植物功能。
Front Immunol. 2020 Aug 26;11:1886. doi: 10.3389/fimmu.2020.01886. eCollection 2020.
8
Deceased Donor Renal Transplantation: 6 Year Experience from a Tertiary Care Center in North India.尸体供肾移植:印度北部一家三级护理中心的 6 年经验。
J Assoc Physicians India. 2022 Apr;70(4):11-12.
9
Long-term outcomes of kidney transplantation in recipients 60 years of age and older at the University of Florida.佛罗里达大学60岁及以上肾移植受者的长期预后
Clin Transpl. 2005:101-9.
10
Impact of Combinations of Donor and Recipient Ages and Other Factors on Kidney Graft Outcomes.供者和受者年龄组合及其他因素对肾脏移植物结局的影响。
Front Immunol. 2020 May 22;11:954. doi: 10.3389/fimmu.2020.00954. eCollection 2020.

引用本文的文献

1
The effect of pre-transplant dialysis duration on the relationship between delayed graft function and recipient death.移植前透析时间对移植肾功能延迟恢复与受者死亡之间关系的影响。
Sci Rep. 2025 Jul 1;15(1):20821. doi: 10.1038/s41598-025-05893-2.
2
Risk Factors for Solid Organ Graft Failure and Death in Solid Organ Transplant Recipients Undergoing Hematopoietic Cell Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research (CIBMTR) and Organ Procurement and Transplantation Network (OPTN) Study.接受造血细胞移植的实体器官移植受者发生实体器官移植失败和死亡的危险因素:一项国际血液和骨髓移植研究中心(CIBMTR)与器官获取与移植网络(OPTN)的回顾性研究。
Transplantation. 2025 Jun 23. doi: 10.1097/TP.0000000000005377.
3

本文引用的文献

1
Post-Transplant Cardiovascular Disease.移植后心血管疾病。
Clin J Am Soc Nephrol. 2021 Dec;16(12):1878-1889. doi: 10.2215/CJN.00520121. Epub 2021 Sep 23.
2
Retrospective Analysis of the Kidney Donor Profile Index to Predict Patient and Graft Survival at 5 Years Posttransplantation in a Colombian Cohort.回顾性分析肾移植供者特征指数,预测哥伦比亚队列患者和移植物移植后 5 年的存活率。
Transplant Proc. 2021 Sep;53(7):2197-2203. doi: 10.1016/j.transproceed.2021.07.041. Epub 2021 Aug 31.
3
Polyoma BK Virus in Kidney Transplant Recipients: Screening, Monitoring, and Management.
LILRB3 genetic variation is associated with kidney transplant failure in African American recipients.LILRB3基因变异与非裔美国受者的肾移植失败有关。
Nat Med. 2025 May;31(5):1677-1687. doi: 10.1038/s41591-025-03568-z. Epub 2025 Mar 10.
4
Taming the transplant troll: Exploring racial and ethnic disparities in cytomegalovirus infection among kidney transplant patients.驯服移植难题:探究肾移植患者巨细胞病毒感染中的种族和民族差异
PLoS One. 2025 Jan 29;20(1):e0317383. doi: 10.1371/journal.pone.0317383. eCollection 2025.
5
Supervised home-based exercise program in kidney transplant recipients: A pilot pragmatic non-randomized study.肾移植受者居家监督下的运动计划:一项实用的非随机试点研究。
World J Transplant. 2024 Dec 18;14(4):96244. doi: 10.5500/wjt.v14.i4.96244.
6
How far can we go? A 20-year meta-analysis of dental implant survival rates.我们能走多远?一项长达 20 年的牙种植体存活率的荟萃分析。
Clin Oral Investig. 2024 Sep 21;28(10):541. doi: 10.1007/s00784-024-05929-3.
7
Post-Transplant Cardiovascular Disease in Kidney Transplant Recipients: Incidence, Risk Factors, and Outcomes in the Era of Modern Immunosuppression.肾移植受者的移植后心血管疾病:现代免疫抑制时代的发病率、危险因素及结局
J Clin Med. 2024 May 7;13(10):2734. doi: 10.3390/jcm13102734.
8
Is Non-Adherence Associated with Adverse Outcomes in Kidney Transplant Recipients? The Role of Non-Adherence as a Risk and Predictor Factor for Graft Loss and Death.肾移植受者的不依从性与不良结局相关吗?不依从性作为移植物丢失和死亡的风险及预测因素的作用。
Patient Prefer Adherence. 2023 Nov 11;17:2915-2925. doi: 10.2147/PPA.S436833. eCollection 2023.
9
Influence of Surgical Complications on Outcomes in Kidney Transplantation Patients.手术并发症对肾移植患者结局的影响。
In Vivo. 2023 Nov-Dec;37(6):2796-2802. doi: 10.21873/invivo.13392.
10
A Comparative Study on Graft and Overall Survival Rates Between Diabetic and Nondiabetic Kidney Transplant Patients Through Survival Analysis.通过生存分析对糖尿病和非糖尿病肾移植患者的移植物和总生存率进行比较研究。
Can J Kidney Health Dis. 2023 Sep 14;10:20543581231199011. doi: 10.1177/20543581231199011. eCollection 2023.
肾移植受者中的多瘤 BK 病毒:筛查、监测和管理。
Transplantation. 2022 Jan 1;106(1):e76-e89. doi: 10.1097/TP.0000000000003801.
4
Cytomegalovirus Infection in Postrenal Transplant Recipients: 18 Years' Experience From a Tertiary Referral Center.后肾移植受者巨细胞病毒感染:来自一家三级转诊中心的 18 年经验。
Transplant Proc. 2020 Dec;52(10):3173-3178. doi: 10.1016/j.transproceed.2020.02.162. Epub 2020 Jul 2.
5
Impact of Combinations of Donor and Recipient Ages and Other Factors on Kidney Graft Outcomes.供者和受者年龄组合及其他因素对肾脏移植物结局的影响。
Front Immunol. 2020 May 22;11:954. doi: 10.3389/fimmu.2020.00954. eCollection 2020.
6
Living or deceased-donor kidney transplant: the role of psycho-socioeconomic factors and outcomes associated with each type of transplant.活体供肾与尸体供肾移植:心理-社会经济学因素的作用及与每种移植类型相关的结果。
Int J Equity Health. 2020 Jun 1;19(1):79. doi: 10.1186/s12939-020-01200-9.
7
Competing Risk Analysis in Renal Allograft Survival: A New Perspective to an Old Problem.肾移植存活的竞争风险分析:一个老问题的新视角。
Transplantation. 2021 Mar 1;105(3):668-676. doi: 10.1097/TP.0000000000003285.
8
Pathology of the kidney allograft.移植肾病理学。
Semin Diagn Pathol. 2020 May;37(3):148-153. doi: 10.1053/j.semdp.2020.03.005. Epub 2020 Mar 29.
9
Ignoring competing events in the analysis of survival data may lead to biased results: a nonmathematical illustration of competing risk analysis.在生存数据分析中忽略竞争事件可能会导致有偏的结果:竞争风险分析的非数学说明。
J Clin Epidemiol. 2020 Jun;122:42-48. doi: 10.1016/j.jclinepi.2020.03.004. Epub 2020 Mar 9.
10
Outcomes of kidney retransplantation after graft loss as a result of BK virus nephropathy in the era of newer immunosuppressant agents.新型免疫抑制剂时代,因 BK 病毒肾病导致移植物丢失后的肾移植再移植结局。
Am J Transplant. 2020 May;20(5):1334-1340. doi: 10.1111/ajt.15723. Epub 2019 Dec 24.